Pharmacogenetic profiling and clinical outcome of patients (pts) with advanced gastric cancer (AGC) treated with S-1 monotherapy

被引：0
|
作者：
Ichikawa, W. [1 ]
Takahashi, T. [1 ]
Sasaki, Y. [1 ]
机构：
[1] Saitama Med Sch, Iruma, Saitama, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4600
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Association between Helicobacter pylori infection and outcome in advanced gastric cancer patients treated with S-1 adjuvant chemotherapy.
    Nishizuka, Satoshi
    Tamura, Gen
    Nakatochi, Masahiro
    Iwaya, Takeshi
    Espina, Virginia A.
    Liotta, Lance A.
    Koeda, Keisuke
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [32] RETRACTED: S-1 monotherapy as second line chemotherapy in advanced gastric cancer patients previously treated with cisplatin/infusional fluorouracil (Retracted Article)
    Lv, Fangfang
    Liu, Xin
    Wang, Biyun
    Guo, Haiyi
    Li, Jin
    Shen, Lin
    Jin, Maolin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (07): : 4274 - 4279
  • [33] Phase I study of irinotecan (CPT-11) combined with S-1 in patients with advanced gastric cancer(AGC)
    Komatsu, Y
    Takei, M
    Kato, T
    Miyagishima, T
    Kunieda, Y
    Tateyama, M
    Wakahama, O
    Takeda, H
    Kato, M
    Sugiyama, T
    Asaka, M
    Sakata, Y
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 253 - 254
  • [34] Clinical efficacy of S-1 combined with cisplatin for advanced gastric cancer
    Hideo Baba
    Manabu Yamamoto
    Kazuya Endo
    Yasuharu Ikeda
    Yasushi Toh
    Shunji Kohnoe
    Takeshi Okamura
    Gastric Cancer, 2003, 6 (Suppl 1) : 45 - 49
  • [35] Use of a combination of 5-fluorouracil pathway genes to predict treatment outcome of S-1 monotherapy in advanced gastric cancer
    Kim, G.
    Jeung, H.
    Rha, S. Y.
    Roh, J. K.
    Noh, S.
    Chung, H. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [36] Bone metastases (BM) in patients (pts) with locally advanced or metastatic gastric cancer (AGC): Clinical and therapeutic implications
    Liguigli, Wanda
    Toppo, Laura
    Tomasello, Gianluca
    Poll, Rossana
    Ratti, Margherita
    Lazzarelli, Silvia
    Donlda, Blanca Maria
    Passalacqua, Rodolfo
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [37] Surgical outcomes in patients with locally advanced gastric cancer treated with S-1 and oxaliplatin as neoadjuvant chemotherapy
    Feng, Daofu
    Leong, Meiha
    Li, Ting
    Chen, Lin
    Li, Tao
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2015, 13
  • [38] Surgical outcomes in patients with locally advanced gastric cancer treated with S-1 and oxaliplatin as neoadjuvant chemotherapy
    Daofu Feng
    Meiha Leong
    Ting Li
    Lin Chen
    Tao Li
    World Journal of Surgical Oncology, 13
  • [39] Phase I pharmacokinetic study of S-1 plus cisplatin in patients with advanced gastric carcinoma (AGC).
    Ajani, JA
    Yao, J
    Faust, J
    Carr, K
    Anbe, H
    Houghton, M
    Urrea, P
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 324S - 324S
  • [40] Reduction in Gastrointestinal Toxicity by Gastric Secretion Inhibitors during S-1 Monotherapy for Patients with Gastric Cancer
    Chisaki, Yugo
    Noda, Satoshi
    Hira, Daiki
    Morita, Shin-ya
    Yano, Yoshitaka
    Terada, Tomohiro
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2014, 37 (07) : 1158 - 1161
12345